Veteran News Anchor Says He Once Turned To Marijuana for Pain Relief While Battling Multiple Myeloma – What Experts Say About Marijuana and Cancer Patients

Published Jan 10, 2024

Veteran News Anchor Says He Once Turned To Marijuana for Pain Relief While Battling Multiple Myeloma – What Experts Say About Marijuana and Cancer Patients

close

Patient Pathfinder

We’re here to help. Have you had any treatment for myeloma yet?

You might want to check out some top experts outlining the initial treatment for myeloma.

Got it. Are you looking for maintenance treatment?

You might want to check out some top experts outlining maintenance treatment for myeloma.

Ok. Has your Myeloma come back? Here are some useful resources:

If you’ve had at least four treatments that have not worked or stopped working you might be a candidate for a treatment called CAR T Therapy.

NOW
PLAYING
"Resilient Survivor" Comedian Kathy Griffin, 63, Says She Attempted To Take Her Own Life Amid Suicidal Thoughts & Pill Addiction
NOW
PLAYING
TLC's Tionne 'T-Boz' Watkins Didn't Talk About Living With Rare Chronic Illness, Sickle Cell Anemia, Until Adulthood
NOW
PLAYING
Comedian Amy Schumer, 42, Stopped Taking Ozempic After Side Effects Made Her Feel 'So Sick'— What Is The Risk of New Blockbuster Weight Loss Drugs?
NOW
PLAYING
Tattoo Ink Danger: Alarming Percentage Of Inks Have Unlisted, Potentially Harmful Ingredients— Understanding The Risks of Body Art
NOW
PLAYING
"A Relationship Disease" SurvivorNetTV Presents: The Power of Emotional Support For Veterans Handling Prostate Cancer
NOW
PLAYING
A New Relationship With God, Olympic Skater Scott Hamilton, 65, On How His Third Brain Tumor Miraculous Shrunk

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... multiple myeloma trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.